ArticleBMJ open respiratory research2025

Phase 2 study design and analysis approach for BBT-877: an autotaxin inhibitor targeting idiopathic pulmonary fibrosis.

Toby Maher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.